*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : SZ7895000
CHEMICAL NAME : Phosphonic acid, (1,2-epoxypropyl)-, calcium salt
(1:1), (1R,2S)-(-)-
CAS REGISTRY NUMBER : 26016-98-8
LAST UPDATED : 199203
DATA ITEMS CITED : 12
MOLECULAR FORMULA : C3-H5-O4-P.Ca
MOLECULAR WEIGHT : 176.13
WISWESSER LINE NOTATION : T3OTJ BPWO C1 &-CA- &QH
COMPOUND DESCRIPTOR : Drug
Reproductive Effector
SYNONYMS/TRADE NAMES :
* Calcium fosfomycin
* Calcium phosphonomycin
* Fosfomycin calcium
* Fosfomycin calcium salt
* Phosphonic acid, (3-methyloxiranyl)-, calcium salt (1:1), (2R-cis)-
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >7 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: 6,786,1982
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1036 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: 6,785,1982
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >3500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: 6,786,1982
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >3500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: 6,786,1982
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 994 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 11,811,1980
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >3500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: 6,786,1982
** REPRODUCTIVE DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 84 gm/kg
SEX/DURATION : female 14-22 day(s) after conception
lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - weaning or lactation index (e.g., #
alive at weaning per # alive at day 4)
REFERENCE :
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc.,
2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
Volume(issue)/page/year: 33,733,1980
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 15400 mg/kg
SEX/DURATION : female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc.,
2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
Volume(issue)/page/year: 32,546,1979
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 11 gm/kg
SEX/DURATION : male 9 week(s) pre-mating
female 2 week(s) pre-mating
female 1-7 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
REFERENCE :
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc.,
2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
Volume(issue)/page/year: 33,613,1980
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 57 gm/kg
SEX/DURATION : male 9 week(s) pre-mating
female 2 week(s) pre-mating
female 1-7 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc.,
2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
Volume(issue)/page/year: 33,613,1980
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 113 gm/kg
SEX/DURATION : male 9 week(s) pre-mating
female 2 week(s) pre-mating
female 1-7 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - mating performance (e.g. # sperm positive females
per # females mated; # copulations per # estrus cycles)
REFERENCE :
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc.,
2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
Volume(issue)/page/year: 33,613,1980
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 1540 mg/kg
SEX/DURATION : female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
Reproductive - Effects on Newborn - physical
REFERENCE :
JJANAX Japanese Journal of Antibiotics. (Japan Antibiotics Research Assoc.,
2-20-8 Kamiosaki, Shinagawa-ku, Tokyo 141, Japan) V.21- 1968-
Volume(issue)/page/year: 32,546,1979
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
Phosphonic acid,(3-(4-(dimethylamino)phenyl)-4,5-dihydro-5-isoxazolyl)-, monohydrobromide
| 125674-86-4 |
Phosphonic acid, dimethyl ester
| 868-85-9 |
Phosphonic acid,(3-(1,1-dimethylethyl)-4,5-dihydro-5-isoxazolyl)-
| 125674-52-4 |
Phosphonic acid,(4-(diphenylhydroxymethyl)piperidino)-, dibutyl ester
| 125674-52-4 |
Phosphonic acid, (dithiodimethylene)di-, tetramethylester
| 32674-23-0 |
Phosphonic acid,(4-(di-o-tolylhydroxymethyl)piperidino)-, diethylester
| 32674-23-0 |
Phosphonic acid, dodecyl-
| 5137-70-2 |
Phosphonic acid, (1,2-epoxypropyl)-, (1R,2S)-(-)-
| 23155-02-4 |
Phosphonic acid, (1,2-epoxypropyl)-, calcium salt(1:1), (1R,2S)-(-)-
| 26016-98-8 |
Phosphonic acid, 2,3-epoxypropyl-, diethyl ester
| 7316-37-2 |
Phosphine oxide, hexyldipentyl-
| 74038-20-3 |
Phosphonic acid, (1,2-epoxypropyl)-, disodium salt(1R,2S) (-)-
| 26016-99-9 |
Phosphonic acid, 1,2-ethanediylbis-
| 6145-31-9 |
Phosphonic acid, ethenyl-
| 1746-03-8 |
Phosphonic acid, ethenyl-,bis(2-((butoxymethylphosphinyl)oxy)ethyl) ester
| 53529-45-6 |
Phosphonic acid, (2-ethoxyethyl)-, diethyl ester
| 5191-35-5 |
Phosphonic acid, (m-ethylaminophenyl)-
| 100860-49-9 |
Phosphonic acid, ethyl-, bis(p-chlorophenyl) ester
| 100860-49-9 |
Phosphonic acid, ethyl-, butyl p-nitrophenyl ester
| 71002-67-0 |
Phosphonic acid, ethyl-, p-chlorophenyl methyl ester
| 33232-87-0 |
Phosphonic acid, ethyl-, cyclic methylene-o-phenyleneester
| 5853-68-9 |
Phosphine oxide,1,4-piperazinediylbis(bis(1-aziridinyl)-
| 738-99-8 |
Phosphonic acid, ethyl-, ethyl ester, ester withp-hydroxybenzamide
| 74038-41-8 |
Phosphonic acid, ethyl, O-ethylO-(2-(ethylthio)-6-methyl-4-pyrimidinyl) ester
| 25537-46-6 |
Phosphonic acid, ethyl-, ethyl methyl ester
| 5301-65-5 |
Phosphonic acid, ethyl-, ethyl p-nitrophenyl ester
| 546-71-4 |
Phosphonic acid, (2-ethyl-1-hydroxyhexyl)-
| 7506-91-4 |
Phosphonic acid, ethyl-, isopropyl p-nitrophenylester
| 7284-58-4 |
Phosphonic acid, ethyl-, methyl (p-cyanophenyl) ester
| 33232-88-1 |
Phosphonic acid, ethyl-, methylp-(methylsulfonyl)phenyl ester
| 33267-37-7 |
Phosphonic acid, ethyl-, methyl p-nitrophenyl ester
| 15536-01-3 |
Phosphonic acid, ethyl-, methyl p-tolyl ester
| 33232-85-8 |
Phosphine oxide,1,4-piperazinediylbis(bis(1-aziridinyl)-, plusN-(5-(aminosulfonyl)-1,3,4- thiadiazol-2-yl)acetamide
| 72060-03-8 |
Phosphonic acid, ethyl-, monoethyl ester
| 7305-61-5 |
Phosphonic acid, ethylthiomethyl-, dibutyl ester
| 74038-42-9 |
Phosphonic acid, ((ethylthio)methylidyne)tri-,hexaethyl ester
| 3247-33-4 |
Phosphonic acid,((ethylthio)(phenylthio)methylene)bis-, tetraethylester
| 63869-22-7 |
Phosphonic acid,(5-(3-fluorobenzoyl)-2,4-dihydro-3H-pyrazol-3-ylidene)bis-, tetraethyl ester
| 132508-17-9 |
Phosphonic acid, fluoro-, ethyl isopropyl ester
| 132508-17-9 |
Phosphonic acid, p-fluorophenyl-,bis(2-(dimethylamino)ethyl) ester
| 339-32-2 |
Phosphonic acid,(3-(4-fluorophenyl)-4,5-dihydro-5-isoxazolyl)-,dimethyl ester
| 125674-80-8 |
Phosphonic acid,(3-(formylhydroxyamino)-1-propenyl)-, (E)-
| 66508-88-1 |
Phosphonic acid,(3-(formylhydroxyamino)-1-propenyl)-, monopotassiumsalt, (E)-
| 66508-52-9 |
Phosphine oxide, tri(mixed(C4-C7)-alkyl)-
| 66508-52-9 |
Phosphonic acid, (3-(formylhydroxyamino)propyl)-,monosodium salt
| 66508-37-0 |
Phosphonic acid, heptyl-, O-ethyl O-(p-nitrophenyl)ester
| 3015-77-8 |
Phosphonic acid, (hexahydro-1H-azepin-1-yl)-, cyclicO,O,O',O'-neopentanetetrayl ester
| 19341-49-2 |
Phosphonic acid,(hexahydro-3,6-epoxyphthalimido)methyl-, diethylester
| 74038-43-0 |
Phosphonic acid, hexamethylenedi-, tetrabutyl ester
| 63904-89-2 |
Phosphonic acid,(1,6-hexanediylbis(nitrilobis(methylene)))tetrakis-
| 23605-74-5 |
|
|